'Slothbot' takes a leisurely approach to environmental monitoring

For environmental monitoring, precision agriculture, infrastructure maintenance and certain security applications, slow and energy efficient can be better than fast and always needing a recharge. That's where "SlothBot" comes in.

* This article was originally published here

Large placebo-controlled trial confirms safety of proton pump inhibitors (PPIs)

For patients taking proton pump inhibitors (PPIs) to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest. In a large, multi-year, randomized trial studying the safety of proton pump inhibitors (PPIs), researchers find no evidence to support claims that PPIs cause serious health issues such as pneumonia, chronic kidney disease, diabetes and dementia. This research is published in Gastroenterology, the official journal of the American Gastroenterological Association, as an article in press.

* This article was originally published here